NO307965B1 - Pyridazinon-derivater og antiblodplate-middel - Google Patents

Pyridazinon-derivater og antiblodplate-middel

Info

Publication number
NO307965B1
NO307965B1 NO963095A NO963095A NO307965B1 NO 307965 B1 NO307965 B1 NO 307965B1 NO 963095 A NO963095 A NO 963095A NO 963095 A NO963095 A NO 963095A NO 307965 B1 NO307965 B1 NO 307965B1
Authority
NO
Norway
Prior art keywords
hydrogen atom
atom
alkyl group
group
pyridazinone derivatives
Prior art date
Application number
NO963095A
Other languages
English (en)
Norwegian (no)
Other versions
NO963095L (no
NO963095D0 (no
Inventor
Keizo Tanikawa
Takashi Matsumoto
Hiroo Matsumoto
Nobutomo Tsuruzoe
Hitoshi Nakabeppu
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Publication of NO963095D0 publication Critical patent/NO963095D0/no
Publication of NO963095L publication Critical patent/NO963095L/no
Publication of NO307965B1 publication Critical patent/NO307965B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/22Nitrogen and oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO963095A 1994-01-25 1996-07-24 Pyridazinon-derivater og antiblodplate-middel NO307965B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP654194 1994-01-25
PCT/JP1995/000069 WO1995019969A1 (fr) 1994-01-25 1995-01-24 Derive de pyridazinone

Publications (3)

Publication Number Publication Date
NO963095D0 NO963095D0 (no) 1996-07-24
NO963095L NO963095L (no) 1996-09-24
NO307965B1 true NO307965B1 (no) 2000-06-26

Family

ID=11641211

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963095A NO307965B1 (no) 1994-01-25 1996-07-24 Pyridazinon-derivater og antiblodplate-middel

Country Status (16)

Country Link
US (2) US5750523A (ko)
EP (1) EP0742211B1 (ko)
KR (1) KR100318653B1 (ko)
CN (1) CN1049892C (ko)
AT (1) ATE192741T1 (ko)
AU (1) AU1466395A (ko)
CA (1) CA2181901C (ko)
DE (1) DE69516849T2 (ko)
DK (1) DK0742211T3 (ko)
ES (1) ES2147841T3 (ko)
FI (1) FI112214B (ko)
HU (1) HU223963B1 (ko)
NO (1) NO307965B1 (ko)
PT (1) PT742211E (ko)
TW (1) TW420665B (ko)
WO (1) WO1995019969A1 (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL110040A (en) * 1993-06-29 2000-07-16 Nissan Chemical Ind Ltd Pyridazinone derivatives their preparation and pharmaceutical compositions comprising them
TW482675B (en) * 1997-01-31 2002-04-11 Green Cross Corp Compositions for oral administration containing pyridazinone compounds technical field of the invention
RU2229297C2 (ru) 1998-09-01 2004-05-27 Ниссан Кемикал Индастриз, Лтд. Терапевтический агент для лечения стеноза позвоночного канала
RU2229885C2 (ru) * 1998-12-07 2004-06-10 Ниссан Кемикал Индастриз, Лтд. Средство для лечения нарушения функции эрекции
ES2195785B1 (es) * 2002-05-16 2005-03-16 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
JP4783152B2 (ja) * 2004-02-09 2011-09-28 日産化学工業株式会社 血管内膜肥厚抑制薬
KR100854584B1 (ko) 2006-03-20 2008-08-27 주식회사 엘지생명과학 피리다지논, 피리미돈 또는 피리돈 구조를 포함하는선택적인 트롬빈 억제제

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1265798A (en) * 1984-12-10 1990-02-13 Motoo Mutsukado 3(2h)pyridazinone, process for its preparation and anti-allergic agent containing it
JPH0641454B2 (ja) * 1985-02-27 1994-06-01 日産化学工業株式会社 ピリダジノン誘導体
US4892947A (en) * 1985-04-27 1990-01-09 Nissan Chemical Industries Ltd. 3(2H)Pyridazinone, process for its preparation and anti-allergic agent containing it
US4978665A (en) * 1987-01-20 1990-12-18 Nissan Chemical Industries Ltd. 3(2H)pyridazinone, and antagonistic agent against SRS-A containing it
JPH02256668A (ja) * 1988-12-20 1990-10-17 Nissan Chem Ind Ltd ピリダジノン誘導体
ATE194835T1 (de) * 1990-04-25 2000-08-15 Nissan Chemical Ind Ltd Pyridazinonderivat
JPH0517357A (ja) * 1991-07-05 1993-01-26 Nissan Chem Ind Ltd 血小板減少療法剤
IL110040A (en) * 1993-06-29 2000-07-16 Nissan Chemical Ind Ltd Pyridazinone derivatives their preparation and pharmaceutical compositions comprising them
ATE173471T1 (de) * 1993-09-06 1998-12-15 Ishihara Sangyo Kaisha Pyridazinonderivate oder deren salze, verfahren zu ihrer herstellung und diese enthaltende antischockmittel

Also Published As

Publication number Publication date
KR100318653B1 (ko) 2002-04-22
FI962957A (fi) 1996-07-24
ES2147841T3 (es) 2000-10-01
HUT74742A (en) 1997-02-28
AU1466395A (en) 1995-08-08
WO1995019969A1 (fr) 1995-07-27
ATE192741T1 (de) 2000-05-15
FI962957A0 (fi) 1996-07-24
CA2181901C (en) 2005-09-13
CN1049892C (zh) 2000-03-01
DE69516849T2 (de) 2000-10-12
EP0742211A1 (en) 1996-11-13
CN1138852A (zh) 1996-12-25
FI112214B (fi) 2003-11-14
CA2181901A1 (en) 1995-07-27
NO963095L (no) 1996-09-24
EP0742211B1 (en) 2000-05-10
TW420665B (en) 2001-02-01
EP0742211A4 (en) 1997-03-26
HU223963B1 (hu) 2005-03-29
HU9602021D0 (en) 1996-09-30
DK0742211T3 (da) 2000-08-14
US5856327A (en) 1999-01-05
NO963095D0 (no) 1996-07-24
US5750523A (en) 1998-05-12
DE69516849D1 (de) 2000-06-15
PT742211E (pt) 2000-10-31

Similar Documents

Publication Publication Date Title
DE69716226D1 (de) Difluoroprostaglandin-Derivate und ihre Anwendung
AU1039688A (en) 3(2h)pyridazinone, process for its preparation and antagonistic agent against srs-a containing it
AU591640B2 (en) Quinolonecarboxylic acid derivatives
ATE143014T1 (de) Benzimidazol-derivate und therapeutische, diese enthaltende mittel gegen ulcer
ATE172463T1 (de) Pyrrolocarbazol
HUP0004142A2 (hu) 5-HT1F agonista hatású karboxamidszármazékok és a vegyületeket tartalmazó gyógyászati készítmények
DE3767778D1 (de) Entzuendung verhindernde und allergie heilende mittel.
EP0259835A3 (en) Pyridazinone derivatives
NO307965B1 (no) Pyridazinon-derivater og antiblodplate-middel
MX9701949A (es) Derivados de distamicina substituidos con bis-(2-haloetil) aminofenilo como agentes antitumorales y antivirales.
ATE9892T1 (de) Dibenzocycloheptenylidene und ihre verwendung in pharmazeutischen zusammensetzungen.
ATE126504T1 (de) 1-phenoxycarbonyl-2-pyrrolidon-derivate und nootrope wirkstoffe.

Legal Events

Date Code Title Description
MK1K Patent expired